Company intelligence / Profile preview

AB Biotek

Hampton, Cambridgeshire, United Kingdomabbiotek.com ↗

Ownership: Private
Employees: ~38
Development stage: Commercial

Overview

AB Biotek delivers customized fermentation-based solutions containing proprietary or purposefully sourced microorganisms for food, beverage, nutrition, and animal feed industries. Its life science arm—ABbiotek Health—develops microbiome-modulating products for pharma/nutrition markets. No clinical trial results are reported; products are commercialized as supplements or ingredients.

Therapeutic areas: Metabolic DisordersImmunologyRheumatologyGastroenterologyNeurologyWomen's Health
Modalities: Microbial therapyEnzyme-based therapy
Industry: Non-Drug Biotech

Partnerships

Omega Yeast Labs (via parent group)

Beyond the preview

Go deeper on AB Biotek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AB Biotek.

Explore the full profile